Skinvisible, Inc.
SKVI
$0.25
-$0.05-16.67%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| SG&A Expenses | 496.10K | 580.70K | 598.80K | 605.50K | 589.10K |
| Depreciation & Amortization | 20.20K | 20.20K | 21.00K | 20.70K | 20.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 516.40K | 600.90K | 619.80K | 626.30K | 609.60K |
| Operating Income | -496.40K | -580.90K | -599.80K | -606.30K | -589.60K |
| Income Before Tax | -1.06M | -490.80K | -527.20K | -556.20K | -565.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.06 | -0.49 | -0.53 | -0.56 | -0.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.06M | -490.80K | -527.20K | -556.20K | -565.60K |
| EBIT | -496.40K | -580.90K | -599.80K | -606.30K | -589.60K |
| EBITDA | -476.10K | -560.70K | -578.80K | -585.50K | -569.10K |
| EPS Basic | -0.20 | -0.10 | -0.12 | -0.13 | -0.15 |
| Normalized Basic EPS | -0.12 | -0.06 | -0.07 | -0.08 | -0.09 |
| EPS Diluted | -0.20 | -0.10 | -0.12 | -0.13 | -0.15 |
| Normalized Diluted EPS | -0.12 | -0.06 | -0.07 | -0.08 | -0.09 |
| Average Basic Shares Outstanding | 21.57M | 22.80M | 21.93M | 21.07M | 20.25M |
| Average Diluted Shares Outstanding | 21.57M | 22.80M | 21.93M | 21.07M | 20.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |